Key facts
- Evolved By Nature’s last known valuation is $560.0M (Dec 2025).
- It has raised $290.2M across 1 recorded rounds; the latest was Later Stage VC (Series C) ($140.0M) in May 2022.
- Notable investors include Teachers' Venture Growth, Ontario Teachers' Pension Plan, Emerald Development Managers, Mousse Partners, Senator Investment Group — 24 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for Evolved By Nature
Funding rounds
1 roundsAbout Evolved By Nature
Manufacturer of skincare products designed to enhance skin and diminish wrinkles. The company's products are made from liquid silk technology that offers effective stabilization and delivery of real silk molecules to the skin with advanced anti-aging benefits, enabling consumers to use skincare products with no synthetic fillers and eliminating harsh preservatives.
- Industry
- Personal Products
- Sector
- Consumer Products and Services (B2C)
- HQ
- Needham, MA, United States
- Founded
- 2013
- Employees
- 65
- Website
- biotech.evolvedbynature.com/
- Ownership
- Privately Held (backing)
Evolved By Nature doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evolved By Nature shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evolved By Nature in its N-PORT filings yet. We sweep new filings monthly.